Key result
Menopausal transition is linked to substantial lipid surges independent of chronological aging.
Why the study?
Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?
Cohort (n=1,054)
Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?
Answers are grounded in this paper and cite their sources.
Women experience a unique, menopause-induced rise in atherogenic lipids (total cholesterol, LDL-C, apo-B) around the time of their final menstrual period, independent of chronological aging.
OBJECTIVES This prospective study examined if changes in traditional and novel coronary heart disease (CHD) risk factors are greater within a year of the final menstrual period (FMP), relative to changes that occur before or after that interval, in a multi-ethnic cohort. BACKGROUND Understanding the influence of the menopause on CHD risk remains elusive and has been evaluated primarily in Caucasian samples. METHODS The Study of Women’s Health across the Nation (SWAN) is a prospective study of the menopausal transition in 3302 minority (African American, Hispanic, Japanese, or Chinese) and Caucasian women. After 10 annual exams, 1054 women had achieved a FMP not due to surgery and without HT use prior to FMP. Measured CHD risk factors included lipids and lipoproteins, glucose, insulin, blood pressure, fibrinogen, and C-reactive protein. We compared which of two models provided a better fit to the observed risk factor changes over time in relation to FMP: a linear model, consistent with chronological aging, or a piece-wise linear model, consistent with ovarian aging. RESULTS Only total cholesterol, LDL-C, and apolipoprotein-B demonstrated substantial increases within the 1 year interval before and after FMP, consistent with menopause-induced changes. This pattern was similar across ethnic groups. The other risk factors were consistent with a linear model, indicative of chronological aging. CONCLUSIONS Women experience a unique rise in lipids at the time of FMP. Monitoring lipids in perimenopausal women should enhance primary prevention of CHD.
No takes yet. Share an insight, caveat, or question.
Matthews et al. (2009) conducted a cohort in Coronary heart disease risk factors during menopausal transition (n=1,054). Menopausal transition (1-year interval around final menstrual period) vs. Chronological aging (linear model) was evaluated on Changes in CHD risk factors (lipids, lipoproteins, glucose, insulin, blood pressure, fibrinogen, and C-reactive protein). The 1-year interval around the final menstrual period was associated with substantial increases in total cholesterol, LDL-C, and apolipoprotein-B, whereas other risk factors tracked with chronological aging.
Synapse has enriched 10 related papers. Consider them for comparative context: